Belviq (lorcaserin) is the “freshest” prescription diet pill that has been approved by the United States Food and Drug Administration (FDA) in 13 long years! The million dollar question here is— why now?
You probably know that weight loss supplements have been associated with vicious side effects, such as increased risk of heart problems and liver failure. In fact the last weight loss drug approved by the FDA is Xenical (Orlistat), which is also considered the safest.
Apart from curbing the appetite and hunger pangs, Serotonin is also connected to mood and most antidepressants prevent the reuptake of serotonin, which also keeps the brain saturated with the chemical. Then again, Arena Pharmaceuticals researchers state that their drug only affects serotonin receptors that influence appetite.
The clinical trial reported by Arena Pharmaceuticals to the FDA indicates that almost half of the subjects who used Belviq and do not suffer from Type 2 diabetes lost at least 5% of their initial weight. This sums to an average of 12 pounds after 12 weeks of use.
For optimal results, the manufacturer advises dieters to combine a healthy diet and regular exercise while using Belviq. The drug is taken twice a day and is approved by the FDA for obese adults with a body mass index (BMI) of at least 30. FDA says even overweight people having a BMI of 27 and up and suffering from one of weight-induced ailments such as hypertension, high cholesterol or Type 2 diabetes can use Belviq may use Belviq.
Belviq: Positive Features
Safe and Effective – Unlike most diet pills on the market, Belviq has gone through a long and thorough approval process by the FDA.
Value for Money – You can be assured that you are not wasting your money when you buy this weight loss supplement.
Belviq: Negative Features
The main drawback of Belviq is the side effects it may cause.
For non-diabetic patients:
Common side effects may include dizziness, headaches, fatigue, nausea, constipation and dry mouth.
For diabetic patients:
Common side effects may include back pains, low blood sugar, fatigue, headaches and cough. There is also some concern about the drug causing tumors in animals and heart-valve defects in humans which is why Belviq was denied approval by the FDA in 2010.
However, the company behind the drug provided new data proving that a low dose does not cause heart problems.
Belviq: Bottom Line
Obesity is a growing problem and the United States that is why drugs like Belviq are in high demand. Belviq works by suppressing the appetite through the activation of brain receptors for serotonin, triggering the feeling of satiety. Simply put, you’ll feel full and satisfied faster, thus less food is consumed.